knowledge -WSS

knowledge

author：fashion 2025-09-29 20:52:20 - browse：42578

Light hits on the portrait of George Washington on a one dollar bill. The portrait is surrounded by white and red tablets coming out of a pill bottle, as well as some coins — coverage from STAT — Adobe

WASHINGTON — Pharmaceutical companies are doing anything they can to stop President Biden’s Medicare program from being able to negotiate prices for their products, including suing the government. Experts say their efforts might actually benefit Biden by reminding voters that he’s taking on big drug companies.

When Democrats passed a law directing Medicare to negotiate drug prices, it was considered a major achievement. The new law, two decades in the making, gives Biden an accomplishment to both tout for himself and criticize Republicans for opposing — no Republicans voted to let Medicare negotiate drug prices.

Medicare price negotiation is popular with voters, as are the law’s price-inflation limits, and it includes additional, direct benefits for older adults that are easy to understand. It caps annual out-of-pocket retail-drug spending for seniors and people with disabilities, and it caps their monthly spending on insulin at $35.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： The 10 drugs up first for Medicare price negotiation

WSS

ALS advocates say criticism of new drugs misses bigger picture

A new initiative will help leaders fight the next pandemic

For pregnant people, addiction treatment shouldn't mean a call to child protective services

For pregnant people, addiction treatment shouldn't mean a call to child protective services

What American doctors can learn from their Israeli counterparts

A new House health package & hospitals’ new site

knowledge

knowledge

Wikipedia

Duchenne breakthrough therapy leaves behind pioneering families

An outdated Medicare rule harms dementia patients with anxiety

In age of alternative facts, a scholarly course on calling out crap

AstraZeneca chief proposes a novel edit to the drug pricing bill

Cancer drug shortages should be causing more outrage

Senators tussle over abortion against the backdrop of a presidential campaign

Hollywood unions extend contract negotiations for actors

BD to buy Edwards patient monitoring unit for $4.2 billion

Sports medicine is finally prioritizing gender equality

FDA approves Moderna’s RSV vaccine, its second licensed product

knowledge

Amazon on where the company's health care bets are headed next

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

How to fix cancer clinical trials' diversity problem

An outdated Medicare rule harms dementia patients with anxiety

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

ASCO Takeaways: Winners, snoozers, and the art of cancer care

hotspot

knowledge

focus

hotspot